{
  "meta": {
    "title": "Intestinal_Infections",
    "url": "https://brainandscalpel.vercel.app/intestinal-infections-f017d90f.html",
    "scrapedAt": "2025-11-29T18:34:47.906Z"
  },
  "questions": [
    {
      "id": 1587,
      "choices": [
        {
          "id": 6343,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">60%</span></span></p>"
        },
        {
          "id": 6344,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">70%</span></span></p>"
        },
        {
          "id": 6345,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">80%</span></span></p>"
        },
        {
          "id": 6346,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">90%</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A medical resident in a family practice clinic is discussing influenza vaccination with patients as part of an annual public health campaign. One of the patients, a 45-year-old woman, asks about the effectiveness of the inactivated influenza vaccine. The resident recalls recent studies and guidelines to provide an informed answer, emphasizing the importance of vaccination in preventing influenza and its complications, especially in adults younger than 65 years of age. What is the effectiveness of the inactivated influenza vaccine in adults younger than 65 years of age?</span></span></p>",
      "unique_key": "Q2381585",
      "question_audio": null,
      "question_video": null,
      "map_id": 34200,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. 60%</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Inactivated influenza vaccine</strong>:&nbsp;The vaccine is about <strong>60 percent effective</strong> among <strong>healthy</strong> persons <strong>younger than 65 years</strong> of age. On vaccination, the <strong>vaccine </strong>becomes <strong>effective</strong> after <strong>14 days</strong>. The <strong>immunity lasts</strong> from <strong>6-12 months</strong>. The vaccine is <strong>50-60 percent effective</strong> in <strong>preventing hospitalization</strong> and <strong>80 percent</strong> <strong>effective </strong>in <strong>preventing death</strong> among elderly persons.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Inactivated Influenza vaccine</strong> - <strong>Trivalent Flu Vaccine</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">&bull; Protection: &ndash; <strong>Two</strong> <strong>influenza A viruses</strong> (an <strong>H1N1</strong> and an <strong>H3N2</strong>)<br />\r\n&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ndash; An <strong>influenza B virus</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">&bull; Types of <strong>Trivalent vaccine</strong>:<br />\r\n&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ndash; <strong>Standard-dose</strong> trivalent shots: Approved for people of <strong>different ages.</strong><br />\r\n&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ndash; <strong>High-dose trivalent shot</strong>: Approved for people <strong>65 and older.</strong><br />\r\n&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &ndash; <strong>Trivalent shot</strong>: Approved for people <strong>18 and older.</strong><br />\r\n&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&ndash; <strong>Recombinant trivalent shot</strong>: Approved for people <strong>18 years</strong> <strong>and older.</strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Contraindications</strong> to <strong>Inactivated Influenza vaccines -&nbsp;</strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Severe <strong>allergy</strong> to <strong>chicken eggs.</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">History of <strong>hypersensitivity/anaphylactic reactions</strong> previously.</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Development of <strong>Guillain-Barr&eacute; Syndrome</strong> (GBS) within <strong>6 weeks</strong> of vaccine.</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Infants less</strong> than <strong>6 month&rsquo;s age.</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Moderate-to-severe illness</strong> with <strong>fever</strong>.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>effectiveness</strong> of the <strong>inactivated influenza vaccine</strong> in <strong>adults younger</strong> than <strong>65 years of age</strong> is typically around <strong>- 50-60%.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26<sup>th</sup> edition (page 173)</strong></span></span></p>",
      "correct_choice_id": 6343,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1655,
      "choices": [
        {
          "id": 6615,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Covishield vaccine</span></span></p>"
        },
        {
          "id": 6616,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Covaxin vaccine</span></span></p>"
        },
        {
          "id": 6617,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pfizer BioNtech vaccine</span></span></p>"
        },
        {
          "id": 6618,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Moderna COVID 19 vaccine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a seminar on the recent advancements in COVID-19 vaccine technology. One of the topics discussed is the variety of vaccine platforms used to combat the pandemic. A particular focus is given to a vaccine developed using a recombinant chimpanzee adenovirus vector. Which COVID-19 vaccine is developed using a recombinant chimpanzee adenovirus vector?</span></span></p>",
      "unique_key": "Q5596132",
      "question_audio": null,
      "question_video": null,
      "map_id": 34201,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. Covishield vaccine</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Covishield vaccine</strong> (<strong>Oxford-AstraZeneca</strong>) is a <strong>recombinant</strong> chimpanzee adenovirus vector vaccine, administered <strong>intramuscularly</strong> in <strong>deltoid muscle</strong>. Given in <strong>two doses</strong>, <strong>28 days apart</strong>. The protective level of<strong> antibodies</strong> are generally developed <strong>two weeks after the 2nd dose</strong> of the vaccine. The vaccine has been approved for individuals <strong>18 years of age and above.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Covaxin vaccine: </strong>&nbsp;Whole <strong>Virion</strong> Inactivated vaccine, strain is &quot;<strong>Niv-2020-770</strong>&quot;.&nbsp; Manufactured by <strong>Bharat Biotech BSL-3 facility</strong> &amp; <strong>ICMR</strong> &amp; <strong>NIV</strong> (<strong>100</strong>% Indigenous vaccine of India). This is for Individuals <strong>&ge;18</strong> years old, given in <strong>2 doses</strong> (<strong>0.5</strong> mL each) <strong>4-6</strong> weeks apart (Route - ONLY Intramuscular, at <strong>Deltoid muscle</strong>).&nbsp;Protective efficacy is <strong>86-96%.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Pfizer BioNTech vaccine:</strong>&nbsp;<strong>mRNA</strong> vaccine. It uses <strong>messenger RNA</strong> to instruct cells to produce the <strong>spike protein</strong> of the virus, <strong>triggering</strong> an <strong>immune response</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Moderna COVID-19 vaccine:</strong> Similar to the <strong>Pfizer BioNTech vaccine,</strong> this is also an <strong>mRNA vaccine</strong> and <strong>operates</strong> on the <strong>same principle.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Covishield vaccine</strong> is a <strong>recombinant</strong> chimpanzee <strong>adenovirus</strong> vector vaccine</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Comparison of some important COVID vaccines </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-125437.png\" style=\"height:825px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26<sup>th</sup> edition (page 203)</strong></span></span></p>",
      "correct_choice_id": 6615,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1714,
      "choices": [
        {
          "id": 6849,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">5 days</span></span></p>"
        },
        {
          "id": 6850,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">15 days</span></span></p>"
        },
        {
          "id": 6851,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">10 days</span></span></p>"
        },
        {
          "id": 6852,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">28 days</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A public health officer is working on a cholera outbreak response in a region. One of the key aspects of managing the outbreak is determining when the area can be declared free of cholera. This involves understanding the criteria based on the time elapsed since the last confirmed case. The officer is reviewing these criteria to ensure that the declaration of cholera freedom in the area is based on sound epidemiological principles and to plan for post-outbreak surveillance. When can an area be declared free of cholera after the death or isolation of the last confirmed case?</span></span></p>",
      "unique_key": "Q9740370",
      "question_audio": null,
      "question_video": null,
      "map_id": 34199,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. &nbsp;C. 10 days</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>An area</strong> is declared <strong>free of cholera</strong> when <strong>twice</strong> the <strong>incubation period</strong> (i.e., <strong>10 days</strong>) has <strong>elapsed</strong> since the <strong>death, recovery or isolation</strong> of the <strong>last case</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Incubation period</strong> of <strong>Cholera</strong> - <strong>1&ndash;2 days</strong> (Few hours&ndash;5 days)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Guidelines for Cholera Control (WHO)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Verification of diagnosis</strong>:</span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Identifying <strong>Vibrio cholerae 01 in stools</strong> of <strong>few patients</strong> is <strong>sufficient</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is <strong>&lsquo;not</strong> necessary to <strong>culture stools</strong> of <strong>all cases or contacts&rsquo;</strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Notification:</strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Cholera</strong> is a notifiable disease <strong>locally, nationally and internationally</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Under <strong>International Health Regulations, Cholera</strong> is notifiable to <strong>WHO </strong>by <strong>national govt</strong> within <strong>24 hours</strong> (<strong>no. of cases &amp; deaths</strong> to be reported <strong>daily and weekly)</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">An <strong>area</strong> is <strong>declared free of Cholera</strong> when <strong>twice</strong> the <strong>IP </strong>has <strong>elapsed since last case.</strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Early case</strong> finding: through <strong>aggressive case</strong> search&nbsp;</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Establishment</strong> of <strong>treatment centres</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Rehydration</strong> therapy: through <strong>ORS</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Adjuncts</strong> to therapy: Only <strong>antibiotics</strong> may be used when <strong>vomiting stops</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-114333.png\" style=\"height:464px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Epidemiological investigations</strong>: General <strong>sanitation</strong> measures, epidemiological studies </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sanitation measures: <strong>Water control, excreta disposal, food sanitation, disinfection</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Chemoprophylaxis:</strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Mass</strong> chemoprophylaxis is <strong>not advised</strong> for <strong>total community</strong>; is only advisable for <strong>household contacts</strong> or a<strong>&nbsp;closed community</strong>.</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Drug of choice</strong> for chemoprophylaxis: <strong>Tetracycline</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>To prevent</strong> one case of cholera, <strong>10,000</strong> persons need to be given <strong>chemoprophylaxis.</strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Vaccination</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Health education</strong>: <strong>Most effective</strong> prophylactic measure</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">An area is <strong>declared free of Cholera</strong> when <strong>twice</strong> the <strong>IP </strong>has <strong>elapsed since last</strong> <strong>case </strong>(i.e<strong>. 10 days</strong>)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26<sup>th</sup> edition (page 270)</strong></span></span></p>",
      "correct_choice_id": 6851,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1992,
      "choices": [
        {
          "id": 7961,
          "text": "<p><span style=\"font-size:12pt;\">Food safety</span></p>"
        },
        {
          "id": 7962,
          "text": "<p><span style=\"font-size:12pt;\">Immunisation with whole cell killed parenteral vaccine</span></p>"
        },
        {
          "id": 7963,
          "text": "<p><span style=\"font-size:12pt;\">Proper excreta disposal</span></p>"
        },
        {
          "id": 7964,
          "text": "<p><span style=\"font-size:12pt;\">Super chlorination of water</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An epidemiologist working with a global health organization is developing a training module on outbreak response strategies for various infectious diseases. One of the diseases being focused on is cholera, known for its potential to cause rapid and severe outbreaks, especially in areas with poor water and sanitation facilities. The training module aims to outline the key steps and interventions necessary for an effective response to a cholera outbreak. However, it is also important to clarify common misconceptions about what should not be included in these response strategies. The epidemiologist is preparing a question to test the trainees' understanding of these concepts. In the context of an effective response strategy for a cholera outbreak, which of the following steps is NOT typically recommended?</span></p><p>&nbsp;</p>",
      "unique_key": "Q6727905",
      "question_audio": null,
      "question_video": null,
      "map_id": 34189,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. &nbsp;B. Immunisation with whole cell killed parenteral vaccine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Mass vaccination</strong> is <strong>not</strong> recommended in an <strong>outbreak of cholera.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Guidelines for <strong>Cholera Control (WHO):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Verification of diagnosis:</span><ul><li><span style=\"font-size:12pt;\">Identifying <strong>Vibrio cholerae 01</strong> in <strong>stools</strong> of <strong>few patients</strong> is sufficient.</span></li><li><span style=\"font-size:12pt;\">It is ‘<strong>not necessary</strong> to <strong>culture</strong> stools of <strong>all cases or contacts’.</strong></span></li></ul></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Notification:</span></p><ul><li><p style=\"text-align:justify;\"><strong>Cholera</strong> is a notifiable <strong>disease locally, nationally and internationally.</strong></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Under <strong>International Health Regulations</strong>, <strong>Cholera</strong> is notifiable to WHO by <strong>National Govt</strong> within <strong>24 hours</strong> (no. of cases &amp; deaths&nbsp;to be reported daily and weekly).</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">An area is declared <strong>free of Cholera</strong> when <strong>twice</strong> the <strong>IP</strong> has <strong>elapsed</strong> since <strong>last case.</strong></span></p></li></ul></li><li><span style=\"font-size:12pt;\">Early case finding: through aggressive case search&nbsp;</span></li><li><span style=\"font-size:12pt;\">Establishment of treatment centres</span></li><li><span style=\"font-size:12pt;\">Rehydration therapy: through <strong>ORS</strong></span></li><li><span style=\"font-size:12pt;\">Adjuncts to therapy: Only <strong>antibiotics</strong> may be used when <strong>vomiting stops.</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-114613.png\" alt=\"\" width=\"1000\" height=\"803\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Epidemiological investigations</strong>: <strong>General sanitation</strong> measures, <strong>epidemiological studies</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Sanitation</strong> measures: <strong>Water control, excreta disposal</strong>, food sanitation, disinfection</span><ul><li><span style=\"font-size:12pt;\"><strong>Chemoprophylaxis:</strong></span></li><li><span style=\"font-size:12pt;\">Mass chemoprophylaxis is <strong>not advised</strong> for <strong>total community</strong>; is only advisable for <strong>household contacts</strong> or a&nbsp;<strong>closed community.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Drug of choice</strong> for chemoprophylaxis: <strong>Tetracycline</strong></span></li></ul></li><li><span style=\"font-size:12pt;\">To <strong>prevent one case of cholera</strong>, <strong>10,000 persons</strong> need to be given <strong>chemoprophylaxis.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Health education</strong>: <strong>most effective</strong> prophylactic measure</span></li><li><span style=\"font-size:12pt;\">Vaccination -&nbsp;<strong>Mass vaccination</strong> is <strong>not </strong>recommended</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">CHOLERA ORAL VACCINES</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Dukoral</strong>*&nbsp;(WC-rBS): <strong>Monovalent</strong>, <strong>V cholera O1</strong> plus Recombinant <strong>toxin B</strong> subunit</span></li><li><span style=\"font-size:12pt;\"><strong>Sanchol</strong>: <strong>Bivalent,</strong> <strong>Serogroups O1 &amp; O139</strong>, No toxin B subunit, No buffer required</span></li><li><span style=\"font-size:12pt;\"><strong>mORCVAX</strong>: <strong>Bivalent, Serogroups O1 &amp; O139</strong>, No toxin B subunit, No buffer required</span></li><li><span style=\"font-size:12pt;\"><strong>CVD103-HgR</strong>: <strong>Live attenuated, single dose</strong>, <strong>not</strong> produced now</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">*<strong>Dukoral</strong>®&nbsp;is mainly used for <strong>travellers</strong>. <strong>Two doses</strong> of Dukoral® provide <strong>protection </strong>against <strong>cholera</strong> <strong>for 2 years.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Steps</strong> taken during an <strong>outbreak of cholera</strong> - <strong>Verification</strong> of <strong>diagnosis</strong>, <strong>Notification</strong>, <strong>early case</strong> finding, <strong>treatment &amp; chemoprophylaxis</strong> for <strong>household contacts,</strong> <strong>sanitation</strong> measures and <strong>health education.</strong>&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Mass vaccination</strong> is <strong>not</strong> recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Textbook of Community Medicine- Rajvir Bhalwar- 4<sup>th</sup> edition (page 680)</strong></span></p>",
      "correct_choice_id": 7962,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1994,
      "choices": [
        {
          "id": 7969,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dukoral</span></span></p>"
        },
        {
          "id": 7970,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Euvichol</span></span></p>"
        },
        {
          "id": 7971,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lakichol</span></span></p>"
        },
        {
          "id": 7972,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sanchol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A nurse educator is conducting a training session for a group of nursing students who are about to start their clinical rotations in a travel medicine clinic. The focus of the session is on vaccines, particularly those administered orally, as travellers often seek advice on preventive measures against diseases like cholera. The educator wants to ensure that the students can correctly identify which oral vaccines are specifically for cholera and which are not, as this knowledge is crucial for providing accurate travel health advice. In the context of travel medicine, which of the following oral vaccines is NOT used for the prevention of cholera?</span></span></p>",
      "unique_key": "Q3520123",
      "question_audio": null,
      "question_video": null,
      "map_id": 34191,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Lakichol</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>CHOLERA ORAL VACCINES</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Dukoral (WC-rBS):</strong> <strong>Monovalent, V cholera O1 plus</strong> <strong>Recombinant toxin B subunit.</strong>&nbsp;Dukoral&reg;&nbsp;is mainly used for <strong>travellers</strong>.<strong> Two doses of Dukoral</strong>&reg; provide <strong>protection</strong> against <strong>cholera for 2 years</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.&nbsp; Euvichol and&nbsp;Option D. Sanchol: Bivalent</strong>, <strong>Serogroups O1 &amp; O139</strong>, <strong>No toxin B subunit</strong>, <strong>No buffer</strong> required Shanchol&trade; and Euvichol&reg; are&nbsp;essentially the <strong>same vaccine</strong> produced by <strong>two different manufacturers</strong>. They <strong>do not</strong> require a <strong>buffer solution</strong> for <strong>administration.</strong> They are given to <strong>all individuals</strong> <strong>over </strong>the age of <strong>one year</strong>.&nbsp;<strong>Shanchol&trade; and&nbsp;<em>Euvichol</em>&reg;</strong> provide protection against <strong>cholera</strong> for <strong>3 years</strong>, while a <strong>single dose</strong> provides <strong>short term</strong> <strong>protection</strong>.&nbsp;Shanchol&trade; and Euvichol&reg; are the vaccines currently available for <strong>mass vaccination</strong> campaigns through the <strong>Global OCV Stockpile</strong>, which is <strong>supported </strong>by <strong>Gavi,</strong> the Vaccine Alliance.&nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Vaccines: </strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Morcvax</strong>: <strong>Bivalent,</strong> Serogroups <strong>O1 &amp; O139</strong>, <strong>No toxin B subunit</strong>, <strong>No buffer</strong> required</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>CVD103-HgR</strong>: <strong>Live attenuated, single dose</strong>, NOT produced now</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Three types of <strong>oral cholera vaccines</strong> are available: (A) Dukoral (WC-rBS). (D) Sanchol and mORCVAX and (B) Euvichol. The live attenuated single-dose vaccine (CVD103-HgR) is no longer produced.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26<sup>th</sup> edition (page 267)</strong></span></span></p>",
      "correct_choice_id": 7971,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1997,
      "choices": [
        {
          "id": 7981,
          "text": "<p><span style=\"font-size:12pt;\">Blood culture</span></p>"
        },
        {
          "id": 7982,
          "text": "<p><span style=\"font-size:12pt;\">Gastric aspirate</span></p>"
        },
        {
          "id": 7983,
          "text": "<p><span style=\"font-size:12pt;\">Stool culture</span></p>"
        },
        {
          "id": 7984,
          "text": "<p><span style=\"font-size:12pt;\">Widal test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A medical researcher is reviewing diagnostic protocols for various bacterial infections. One of the conditions under discussion is typhoid fever, caused by Salmonella typhi. Accurate and timely diagnosis is crucial for the effective management of typhoid fever. The researcher is learning about the various methods used to diagnose this condition and is asked to identify the mainstay of diagnosis for typhoid fever.&nbsp;What is the mainstay of diagnosis for typhoid fever?</span></p>",
      "unique_key": "Q8109176",
      "question_audio": null,
      "question_video": null,
      "map_id": 34194,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Blood culture</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Blood culture</strong> is the <strong>mainstay</strong> of <strong>diagnosis of Typhoid culture</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Blood culture</strong> is the <strong>gold standard</strong> for diagnosing <strong>typhoid fever</strong>, especially in the <strong>early stages&nbsp;(first week)</strong> of the illness. It has <strong>high specificity and sensitivity,</strong> although the yield can <strong>decrease</strong> as the <strong>disease progresses</strong> or if the patient has <strong>taken antibiotics</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Gastric aspirate:&nbsp;</strong> Not used due to low yield</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Stool Culture</strong>: &nbsp;Stool cultures can be used for the <strong>diagnosis</strong> of <strong>typhoid fever,</strong> particularly in the <strong>later stages (3rd week)</strong> of the disease.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Widal test: </strong>The Widal test, which measures <strong>agglutinating antibody levels</strong> against <strong>Salmonella antigens</strong>, It has&nbsp;<strong>Moderate sensitivity &amp; specificity</strong>.&nbsp; It is used in settings where <strong>blood culture</strong> facilities are <strong>not</strong> available.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Mainstay of diagnosis of Typhoid fever - Blood Culture</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Laboratory Diagnosis: <strong>‘BASU’</strong> Mnemonic</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-124354.png\" alt=\"\" width=\"1000\" height=\"814\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Park 26<sup>th</sup> edition (page 273)</strong></span></p>",
      "correct_choice_id": 7981,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1998,
      "choices": [
        {
          "id": 7985,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Heat killed whole cell vaccine</span></span></p>"
        },
        {
          "id": 7986,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Live oral vaccine</span></span></p>"
        },
        {
          "id": 7987,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Typhoid conjugate vaccine</span></span></p>"
        },
        {
          "id": 7988,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">None of the above</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a session on vaccine-preventable diseases in a medical school, a professor is discussing various vaccines used for the prevention of typhoid fever. Typhoid fever, caused by Salmonella typhi, can be effectively prevented with vaccination. However, not all types of vaccines are used for this purpose. The professor presents a question to the medical students to identify which of the listed vaccines is not typically used for the prevention of typhoid fever. Which of the following vaccines is NOT used for the prevention of typhoid fever?</span></span></p>",
      "unique_key": "Q6463757",
      "question_audio": null,
      "question_video": null,
      "map_id": 34195,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. Heat killed whole cell vaccine</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>old parenteral killed whole-cell vaccine</strong> was <strong>effective</strong> but produced <strong>strong</strong> <strong>side-effects</strong>. <strong>Two safe and effective vaccines</strong> are now <strong>licensed and available.</strong> One is <strong>based</strong> on <strong>defined subunit antigens</strong>, the <strong>other</strong> on <strong>whole-cell live attenuated bacteria</strong>. <strong>Vi polysaccharide vaccine</strong> and <strong>Ty21a vaccine</strong> are used now.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. &nbsp;Live Oral Vaccine</strong>: &nbsp;<strong>Typhoral Ty21a vaccine</strong>.&nbsp;Contains <strong>&gt;109</strong> viable organism of <strong>attenuated S. typhi</strong>.&nbsp;Schedule: One capsule each on <strong>days 1, 3, 5</strong> (<strong>booster</strong> of <strong>3 doses</strong>, <strong>once</strong> every <strong>3 years</strong>).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. &nbsp;Typhoid conjugate vaccine</strong> -&nbsp;<strong>TYPHIM Vi</strong> Vaccine.&nbsp;<strong>Vi- Polysaccharide</strong> containing <strong>single</strong> dose <strong>I/m or subcutaneous.</strong>&nbsp;<strong>Not</strong> given in age <strong>&lt; 2 years.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Two safe and effective</strong> vaccines are now <strong>licensed</strong> and <strong>available</strong> against <strong>typhoid - Vi polysaccharide vaccine</strong> and <strong>Ty21a vaccine</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Immunization for Typhoid Fever -</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-123808.png\" style=\"height:608px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26<sup>th</sup> edition (page 275)</strong></span></span></p>",
      "correct_choice_id": 7985,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1999,
      "choices": [
        {
          "id": 7989,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Is orally administered.</span></span></p>"
        },
        {
          "id": 7990,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Given for individuals aged more than 2 years.</span></span></p>"
        },
        {
          "id": 7991,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">3 dose regimen is recommended on alternate days.</span></span></p>"
        },
        {
          "id": 7992,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Protective immunity is achieved 7 days after last dose.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An infectious disease specialist is giving a lecture to medical students about various vaccination strategies for preventing globally prevalent diseases. The discussion includes vaccines that are not routinely administered in all countries but are crucial for specific diseases in endemic areas or for travelers. A focus of the lecture is on the Ty21a vaccine for typhoid fever. The specialist aims to test the students&#39; understanding of the unique attributes of the Ty21a vaccine, particularly how it differs from other common vaccines in terms of administration and scheduling. In a lecture about vaccination strategies against typhoid fever, which point should the infectious disease specialist emphasize to highlight a unique characteristic of the Ty21a vaccine?</span></span></p>",
      "unique_key": "Q5466553",
      "question_audio": null,
      "question_video": null,
      "map_id": 34196,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Given for individuals aged more than 2 years.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The vaccine is <strong>licensed</strong> for use in <strong>individual aged &gt; 5 years.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other 3 options</strong> are <strong>correct</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ty21a vaccine:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Orally administered (Option A)</strong> <strong>live attenuated</strong>, <strong>lyophilized </strong>vaccine for Typhoid.&nbsp; Contains <strong>&gt;10<sup>9 </sup>viable organism</strong> of <strong>attenuated S. typhi.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>capsules</strong> are <strong>licensed</strong> for use in individuals <strong>aged &gt;5 years. </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>vaccine</strong> is <strong>administered</strong> every other day; on <strong>1, 3, and 5th day</strong>; a <strong>3-dose</strong> <strong>regimen </strong>is recommended<strong>. (Option C)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">With the <strong>3-dose regimen</strong>, protective <strong>immunity</strong> is achieved <strong>7 days after</strong> the <strong>last dose</strong>. <strong>(Option D)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>recommendation</strong> is to repeat this series every <strong>3 years</strong> for people living in <strong>endemic areas</strong>, and <strong>every year</strong> for <strong>individuals travelling</strong>; from <strong>non-endemic</strong> to <strong>endemic countries</strong>. </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>Ty21a vaccine</strong> may be given <strong>simultaneously</strong> with <strong>other vaccines</strong>, including <strong>live vaccines</strong> against <strong>polio, cholera, and yellow fever</strong>, or the <strong>measles, mumps</strong> and <strong>rubella (MMR)</strong> combination.</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Note - <strong>Stop Proguanil</strong> and <strong>antibacterial drugs 3 days before</strong> and until <strong>3 days</strong> <strong>later of administration.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Immunization for Typhoid Fever</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/24/screenshot-2024-08-24-155851.png\" style=\"height:606px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ty21a vaccine</strong> -&nbsp;<strong>Orally</strong> administered, <strong>live attenuated, lyophilized vaccine</strong>, for individuals aged <strong>&gt;5 years</strong>,&nbsp;<strong>3-dose regimen</strong> (administered every other day </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">on <strong>1, 3, and 5th day</strong>),&nbsp;<strong>protective immunity</strong> is achieved <strong>7 days after the last dose</strong>. &nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Park 26<sup>th</sup> edition (page 275)</strong></span></span></p>",
      "correct_choice_id": 7990,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2000,
      "choices": [
        {
          "id": 7993,
          "text": "<p><span style=\"font-size:12pt;\">Campylobacter</span></p>"
        },
        {
          "id": 7994,
          "text": "<p><span style=\"font-size:12pt;\">Clostridium</span></p>"
        },
        {
          "id": 7995,
          "text": "<p><span style=\"font-size:12pt;\">Salmonella</span></p>"
        },
        {
          "id": 7996,
          "text": "<p><span style=\"font-size:12pt;\">Staphylococcus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A group of individuals presented to a clinic with symptoms of abdominal cramps, diarrhea, and vomiting approximately 2 hours after consuming a milkshake from a local eatery. As a medical resident in gastroenterology, you are tasked with determining the most likely etiological agent responsible for these symptoms. Given the rapid onset of symptoms and the nature of the consumed product, you consider various foodborne pathogens that could be involved. Based on the symptoms and their rapid onset following the consumption of a milkshake, what is the most likely etiological agent responsible for the illness in these individuals?</span></p>",
      "unique_key": "Q6563939",
      "question_audio": null,
      "question_video": null,
      "map_id": 34197,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Staphylococcus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Staphylococcal </strong>food poisoning: (<strong>MC Food Poisoning</strong>)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Agent: <strong>Enterotoxins</strong> of Staphylococcus aureus</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Toxins formed at <strong>35°–37° C&nbsp;</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Toxins are relatively <strong>heat stable</strong> and <strong>resist</strong> <strong>boiling</strong> for <strong>30 min</strong> or more</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Incubation period: <strong>1–6 hours</strong>.</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>IP</strong> is <strong>short</strong> because of ‘<strong>preformed toxin’</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Mechanism of food poisoning: <strong>Intra-dietetic toxins</strong> (ingestion of toxins <strong>pre-formed</strong> in <strong>food</strong>, in which <strong>bacteria</strong> have <strong>grown</strong>)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The foods involved are <strong>salads, custards, milk and milk products</strong> which get contaminated by <strong>staphylococci.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Campylobacter:&nbsp;</strong> An infection caused by <strong>gram negative bacteria</strong> usually from<strong> contaminated food and water.</strong> &nbsp;Infections are often associated with international travel, <strong>undercooked poultry, unpasteurized milk, untreated</strong> <strong>water, and contact</strong> with <strong>farm animals</strong>. It causes <strong>diarrhea</strong>&nbsp;which may be <strong>bloody,</strong> <strong>cramping, abdominal pain, and fever</strong>&nbsp;within <strong>two to five days</strong> after exposure to the bacteria<strong>. Nausea</strong> (a feeling of sickness in the stomach) and <strong>vomiting</strong> may also occur. The illness typically <strong>lasts</strong> about <strong>one week.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>B. Clostridium 2 types: &nbsp;Botulism food poisoning</strong> by <strong>Clostridium botulinum</strong> type <strong>A, B, E</strong>;&nbsp;<strong>IP 12–36 hours</strong>;&nbsp;food poisoning is due to&nbsp;<strong>Intra-dietetic</strong> <strong>toxins</strong>; prominent symptoms are&nbsp;<strong>Dysphagia,&nbsp;Diplopia and&nbsp;Dysarthria</strong>&nbsp;(GIT SYMPOTOMS ARE SLIGHT).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Clostridium perfringens food poisoning</strong> by&nbsp;<strong>Clostridium perfringens</strong> (welchii);&nbsp;<strong>IP&nbsp;6–24 hours</strong>, found&nbsp;on <strong>raw meat and poultry</strong>, in the <strong>soil</strong>, <strong>excreta</strong>.&nbsp;Symptoms are <strong>watery diarrhea and abdominal cramps</strong>.<strong>&nbsp;Rapid recovery</strong> with <strong>no deaths.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Salmonella:</strong> Salmonella bacteria spread by&nbsp;<strong>improper handling</strong> and <strong>cooking of food</strong>. Occurs by <strong>eating contaminated food</strong> such as <strong>undercooked pork</strong> and <strong>poultry meat, dairy products</strong> made from <strong>unpasteurized milk</strong>, <strong>chocolate</strong> or <strong>raw fruit and vegetables</strong>. IP <strong>12-24 hr</strong>.&nbsp;<strong>Some people</strong> with salmonella infection have <strong>no symptoms</strong>. Most people <strong>develop diarrhea</strong>, <strong>fever and stomach</strong> (abdominal) <strong>cramps</strong> within <strong>12 to 72 hours</strong> after exposure. Most<strong> healthy</strong> people <strong>recover within a few days</strong> to a <strong>week</strong> without specific treatment.</span></p><p><span style=\"font-size:12pt;\"><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Incubation period of food poisoning:&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-123108_XcxG8VU.png\" alt=\"\" width=\"1000\" height=\"537\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Some food poisoning causing organisms</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-123453.png\" alt=\"\" width=\"1000\" height=\"546\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Park 26<sup>th</sup> edition (page 276)</strong></span></p>",
      "correct_choice_id": 7996,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2010,
      "choices": [
        {
          "id": 8033,
          "text": "<p><span style=\"font-size:12pt;\">i- c, ii- b, iii- a, iv-d</span></p>"
        },
        {
          "id": 8034,
          "text": "<p><span style=\"font-size:12pt;\">i- c, ii- a, iii- b, iv-d</span></p>"
        },
        {
          "id": 8035,
          "text": "<p><span style=\"font-size:12pt;\">i- d, ii- b, iii- a, iv-c</span></p>"
        },
        {
          "id": 8036,
          "text": "<p><span style=\"font-size:12pt;\">i- d, ii- a, iii- b, iv-c</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">As part of an epidemiology class focusing on foodborne illnesses, medical students are learning about various pathogens and their associated incubation periods. Understanding these incubation periods is crucial for diagnosing foodborne illnesses and identifying the likely causative agents. The professor has provided a list of common foodborne pathogens and a separate list of their typical incubation periods. The students are asked to match each pathogen with its corresponding incubation period. Task: Match the following pathogens with their respective incubation periods for food poisoning.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-120803.png\" alt=\"\" width=\"1000\" height=\"320\"></p>",
      "unique_key": "Q1354522",
      "question_audio": null,
      "question_video": null,
      "map_id": 34202,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. i- c, ii- b, iii- a, iv-d</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Incubation Period of Food Poisonings&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-123108.png\" alt=\"\" width=\"1000\" height=\"537\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Some Important Pointers on Food Poisoning -&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>MC food poisoning</strong> - <strong>Staphylococcus</strong></span></li><li><span style=\"font-size:12pt;\">Food poisoning in <strong>less than 6 hours</strong> - <strong>Staphylococcal FP</strong></span></li><li><span style=\"font-size:12pt;\">Prominent symptoms in <strong>Botulism FP:</strong> <strong>Dysphagia,&nbsp;Diplopia,&nbsp;Dysarthria</strong> (GIT sympotoms are slight)</span></li><li><span style=\"font-size:12pt;\"><strong>Food poisoning</strong> is an example of: <strong>Common source, single exposure epidemic.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Incubation period</strong> of <strong>food poisoning</strong>: <strong>Salmonella 12–24 hours</strong>, <strong>Staphylococcal 1–6 hours, Botulism 12–36 hours, Cl. perfirengens 6–24 hours, B. cereus</strong> (emetic form) <strong>1–6 hours</strong>, <strong>B. cereus</strong> (diarrhoel form) <strong>12–24 hours</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref:</u> Park 26<sup>th</sup> edition (page 277)</strong></span></p>",
      "correct_choice_id": 8033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2013,
      "choices": [
        {
          "id": 8045,
          "text": "<p><span style=\"font-size:12pt;\">Both affected and not affected persons are interviewed</span></p>"
        },
        {
          "id": 8046,
          "text": "<p><span style=\"font-size:12pt;\">Hospitalized persons are interviewed</span></p>"
        },
        {
          "id": 8047,
          "text": "<p><span style=\"font-size:12pt;\">Only affected persons are interviewed</span></p>"
        },
        {
          "id": 8048,
          "text": "<p><span style=\"font-size:12pt;\">Only not affected persons are interviewed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A medical resident is participating in an epidemiology training focused on the investigation of food poisoning outbreaks. Understanding the investigative process is crucial for identifying the source of the outbreak, implementing control measures, and preventing future occurrences. The training covers various aspects of outbreak investigation, including the identification of the pathogen, interviewing affected individuals, and inspecting food handling facilities. The resident is asked to identify a true statement regarding the investigation of a food poisoning outbreak. Which of the following statements is true regarding the investigation of a food poisoning outbreak?</span></p>",
      "unique_key": "Q2748316",
      "question_audio": null,
      "question_video": null,
      "map_id": 34203,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Both affected and not affected persons are interviewed</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Getting <strong>food history</strong> about <strong>suspected meal in a food poisoning</strong> outbreak:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>List of each and every dish</strong> which was <strong>served</strong> during that <strong>meal </strong>is <strong>made.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Each </strong>and <strong>every person</strong> who <strong>attended the meal</strong> is <strong>interviewed.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>History of consumption</strong> of each and every <strong>food item</strong> that was <strong>served </strong>during that <strong>meal is noted.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Information</strong> is <strong>recorded.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>During the Investigation</strong> of <strong>food poisoning outbreak</strong> -&nbsp;<strong>Both affected and not affected</strong> persons <strong>must </strong>be<strong> interviewed</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Textbook of Community Medicine- Rajvir Bhalwar- 4<sup>th</sup> edition (page 672)</strong></span></p>",
      "correct_choice_id": 8045,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2016,
      "choices": [
        {
          "id": 8057,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">To eliminate viral hepatitis as a public health problem.</span></span></p>"
        },
        {
          "id": 8058,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">To ensure universal access to hepatitis C vaccines</span></span></p>"
        },
        {
          "id": 8059,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">To provide accessible and affordable treatment for hepatitis B and C.</span></span></p>"
        },
        {
          "id": 8060,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">To promote awareness and screening for viral hepatitis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A health policy analyst is evaluating various national health initiatives to provide recommendations for resource allocation. One of the programs under review is the National Viral Hepatitis Control Program, which aims to address the public health challenge of viral hepatitis. The analyst is assessing the program&#39;s objectives to determine how well they align with broader public health goals. Understanding the specific aims of the program is crucial for this evaluation, and the analyst needs to identify a goal that is not a part of the program&rsquo;s objectives. In the context of evaluating the National Viral Hepatitis Control Program, which of the following is NOT an objective of the program?</span></span></p>",
      "unique_key": "Q2665991",
      "question_audio": null,
      "question_video": null,
      "map_id": 34187,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. To ensure universal access to hepatitis C vaccines</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Universal</strong> access to <strong>hepatitis C vaccines</strong> - is <strong>not</strong> an objective of the <strong>National Viral Hepatitis Control Program</strong>.&nbsp;Primarily because as of now, there is <strong>no commercially</strong> available <strong>vaccine for hepatitis C</strong>. Hence, ensuring <strong>universal access</strong> to such a vaccine is <strong>not</strong> a <strong>feasible objective.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. To eliminate viral hepatitis as a public health problem:</strong> &nbsp;This is typically a <strong>primary objective of national viral hepatitis programs</strong>, aiming to <strong>reduce </strong>the <strong>incidence and impact</strong> of the <strong>disease</strong> to <strong>non-threatening levels</strong>.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> <strong>To provide accessible and affordable treatment for hepatitis B and C</strong>:&nbsp;</span></span><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">One of the key objectives of program is to ensure that <strong>treatment</strong> for <strong>Hepatitis B and Hepatitis C</strong> is <strong>accessible and affordable</strong>, aiming to&nbsp;<strong>ending Viral Hepatitis</strong> by <strong>2030 (SDG 3.3).</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. To promote awareness and screening for viral hepatitis: </strong><strong>Raising awareness</strong> and <strong>promoting screening</strong> are common objectives, as <strong>early detection</strong> and <strong>public knowledge</strong> are crucial for <strong>control and prevention.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Some important Pointers </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14px\"><span style=\"font-family:Georgia,serif\"><img src=\"https://nvhcp.mohfw.gov.in/assets/images/mainlogo.png\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>National Viral Hepatitis Control Program</strong> has been launched by <strong>Ministry of</strong> <strong>Health and Family Welfare</strong>, Government of <strong>India</strong> on the occasion of the <strong>World Hepatitis Day, 28th July 2018.</strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aim:</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Combat hepatitis</strong> and achieve <strong>country-wide elimination of Hepatitis C</strong> by <strong>2030;</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Achieve significant <strong>reduction </strong>in the <strong>infected population</strong>, <strong>morbidity</strong>, and <strong>mortality</strong> associated with <strong>Hepatitis B and C</strong> Viz. <strong>Cirrhosis and Hepatocellular carcinoma (liver cancer);</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Reduce </strong>the <strong>risk, morbidity and mortality</strong> due to <strong>Hepatitis A and E.</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The key components include:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1. <strong>Preventive component</strong>: This remains the cornerstone of the <strong>NVHCP</strong>. It will include</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Awareness generation</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Immunization of <strong>Hepatitis B</strong> (birth dose, high risk groups, health care workers)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Safety of blood and blood products</strong> </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;<strong>Injection safety</strong>, safe socio-cultural practices</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Safe drinking water, hygiene and sanitary toilets</strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">2<strong>. Diagnosis and Treatment</strong>:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Screening</strong> of <strong>pregnant women</strong> for <strong>HBsAg</strong> to be done in areas where institutional deliveries are <strong>&lt; 80%</strong> to ensure their <strong>referral</strong> for <strong>institutional delivery for birth</strong> dose <strong>Hepatitis B vaccination.</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Free screening, diagnosis and treatment</strong> for <strong>both hepatitis B and C</strong> would be made available <strong>at all levels</strong> of <strong>health care</strong> in a phased manner.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Provision of <strong>linkages</strong>, including with <strong>private sector</strong> and <strong>not-for-profit</strong> <strong>institutions</strong>, for <strong>diagnosis and treatment.</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Engagement</strong> with <strong>community/peer support</strong> to enhance and ensure adherence to <strong>treatment and demand generation</strong>.</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">3. <strong>Monitoring and Evaluation, Surveillance</strong> and <strong>Research Effective</strong> linkages to the <strong>surveillance system</strong> would be <strong>established</strong> and <strong>operational research</strong> would be undertaken through <strong>Department of Health Research (DHR).</strong> <strong>Standardised M&amp;E</strong> framework would be <strong>developed </strong>and an <strong>online web</strong> based system <strong>established.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">4. <strong>Training and Capacity Building:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This would be a <strong>continuous process</strong> and will be supported by <strong>NCDC, ILBS </strong>and <strong>state tertiary care institutes</strong> and <strong>coordinated by NVHCP</strong>. The <strong>hepatitis induction </strong>and <strong>update programs</strong> for <strong>all level of health care workers</strong> would be made available using both, the <strong>traditional cascade</strong> model of <strong>training</strong> through <strong>master trainers</strong> and various platforms available for <strong>enabling electronic</strong>, <strong>e-learning and e-courses.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>National viral hepatitis</strong> control programs <strong>aim</strong> to <strong>eliminate</strong> the <strong>disease</strong> as a <strong>public health problem</strong>, <strong>provide treatment,</strong> and <strong>promote awareness</strong> and <strong>screening</strong>, they <strong>do not</strong> typically include the <strong>objective</strong> of <strong>ensuring universal access to hepatitis C vaccines</strong>, mainly <strong>due</strong> to the current <strong>unavailability</strong> of such <strong>vaccines.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref:</u></strong><strong> https://www.nhp.gov.in/national-viral-hepatitis-control-program-(nvhcp)_pg</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "correct_choice_id": 8058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2021,
      "choices": [
        {
          "id": 8077,
          "text": "<p><span style=\"font-size:12pt;\">Rapid and feeble pulse</span></p>"
        },
        {
          "id": 8078,
          "text": "<p><span style=\"font-size:12pt;\">Skin pinch retracts on 4 seconds</span></p>"
        },
        {
          "id": 8079,
          "text": "<p><span style=\"font-size:12pt;\">Thirsty and restless</span></p>"
        },
        {
          "id": 8080,
          "text": "<p><span style=\"font-size:12pt;\">Very dry tongue</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A two-year-old child is brought to the emergency department by his parents with symptoms of diarrhea and vomiting for the past 24 hours. The child appears lethargic, and the parents report that he has not had a wet diaper in over 6 hours. The medical team is assessing the child for dehydration, a common complication of gastrointestinal illness in young children. One of the residents is tasked with evaluating the severity of the child's dehydration to determine the appropriate treatment plan.&nbsp; In assessing the severity of dehydration in this two-year-old child, which of the following is NOT a clinical findings would most likely indicate SEVERE dehydration?</span></p>",
      "unique_key": "Q7665429",
      "question_audio": null,
      "question_video": null,
      "map_id": 34188,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Thirsty and restless</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Thirsty and restless</strong> is symptom of <strong>Some Dehydration</strong>, <strong>NOT</strong> Severe&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other 3 options</strong> are <strong>sign/ symptoms</strong> of <strong>Severe Dehydration.&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Sign/ symptom</strong> of <strong>Severe dehydration</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Patient appearance- <strong>Drowsy, limp, cold, sweaty,</strong> maybe <strong>comatose.</strong></span></li><li><span style=\"font-size:12pt;\">Radial pulse- <strong>Rapid, feeble</strong>, sometimes <strong>impalpable</strong></span></li><li><span style=\"font-size:12pt;\">Blood pressure- <strong>Less than 80 mmHg</strong>, may be <strong>unrecordable</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Skin elasticity</strong>- <strong>Pinch retracts very slowly</strong> (more than 2 seconds)</span></li><li><span style=\"font-size:12pt;\"><strong>Tongue- Very dry</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Anterior fontanelle</strong>- <strong>Very sunken</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">IMNCI guidelines for dehydration and diarrhoea</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:14px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/picture33.jpg\" alt=\"\" width=\"700\" height=\"578\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Reference: Park 26<sup>th</sup> edition (page 262)</strong></span></p>",
      "correct_choice_id": 8079,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2025,
      "choices": [
        {
          "id": 8093,
          "text": "<p><span style=\"font-size:12pt;\">Campylobacter jejuni</span></p>"
        },
        {
          "id": 8094,
          "text": "<p><span style=\"font-size:12pt;\">Entamoeba histolytica</span></p>"
        },
        {
          "id": 8095,
          "text": "<p><span style=\"font-size:12pt;\">Rotavirus</span></p>"
        },
        {
          "id": 8096,
          "text": "<p><span style=\"font-size:12pt;\">Shigella</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 3-year-old child presents to the pediatric clinic with a 2-day history of diarrhea. The mother reports that the child has had several episodes of loose stools, some of which contained blood. The child does not have a fever and appears otherwise healthy. The pediatric resident examining the child is considering various infectious causes of bloody diarrhea (dysentery) and recalls that certain pathogens are more commonly associated with this presentation than others. The resident needs to identify which pathogen is least likely to be the cause of this child's bloody diarrhea. Based on the clinical presentation, which of the following pathogens is the least likely cause of bloody diarrhea in this child?</span></p>",
      "unique_key": "Q8674213",
      "question_audio": null,
      "question_video": null,
      "map_id": 34190,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Rotavirus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The <strong>most</strong> common <strong>symptoms</strong> of <strong>rotavirus</strong> are <strong>severe watery diarrhea</strong>, <strong>vomiting</strong>, <strong>fever</strong>, and/or <strong>abdominal pain</strong>. Symptoms usually <strong>start</strong> about <strong>two days</strong> <strong>after</strong> a person is <strong>exposed to rotavirus</strong>. <strong>Vomiting and watery diarrhea</strong> can <strong>last&nbsp;three to eight days</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Campylobacter jejuni</strong> -&nbsp;<strong>Campylobacter infection</strong> usually have <strong>diarrhea</strong> (often <strong>bloody)</strong>, <strong>fever</strong>, and <strong>stomach cramps</strong>. <strong>Nausea and vomiting</strong> may <strong>accompany</strong> the <strong>diarrhea</strong>. Symptoms usually <strong>start two to five days</strong> after <strong>infection</strong> and <strong>last about one week</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Entamoeba histolytica: Invasive intestinal parasitic infection</strong> can result in symptoms of <strong>fulminant dysentery</strong>, such as <strong>fever, chills, bloody</strong> or <strong>mucous diarrhea</strong>, and <strong>abdominal discomfort</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Shigella: Shigellosis </strong>usually start experiencing <strong>symptoms 1 to 2 days</strong> after <strong>contact</strong> with <strong>the germ</strong>. These symptoms include:&nbsp;<strong>Diarrhea </strong>that can be <strong>bloody or prolonged</strong>&nbsp;(lasting <strong>more than 3 days</strong>).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Causes of acute gastroenteritis with blood in stool:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Bacteria</strong>- Shigellosis, enterohemorrhagic E coli, C. jejuni, Salmonella spp, Yersinia enterocolitica</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Protozoa-</strong> Entamoeba histolytica, Balantidium coli</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Helminths</strong>- Massive trichuris infection, Schistosoma mansoni, S.japonicum</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Rota virus</strong>, <strong>Noro virus&nbsp;</strong>is the <strong>least</strong> likely cause of <strong>bloody diarrhea.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Causes of <strong>acute gastroenteritis</strong> with <strong>blood in stool</strong> -&nbsp;<strong>Shigellosis,</strong> <strong>enterohemorrhagic E coli, C. jejuni</strong>, <strong>Salmonella spp, Yersinia enterocolitica,&nbsp;Entamoeba histolytica, Balantidium coli,&nbsp;Massive trichuris infection, Schistosoma mansoni, S.japonicum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Textbook of Community Medicine- Rajvir Bhalwar- 4<sup>th</sup> edition (page 661)</strong></span></p>",
      "correct_choice_id": 8095,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2027,
      "choices": [
        {
          "id": 8101,
          "text": "<p><span style=\"font-size:12pt;\">1 mg</span></p>"
        },
        {
          "id": 8102,
          "text": "<p><span style=\"font-size:12pt;\">5 mg</span></p>"
        },
        {
          "id": 8103,
          "text": "<p><span style=\"font-size:12pt;\">10 mg</span></p>"
        },
        {
          "id": 8104,
          "text": "<p><span style=\"font-size:12pt;\">20 mg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pediatric resident is managing a 7-month-old child who presented to the clinic with acute diarrhea. As part of the treatment plan, the resident decides to include zinc supplementation, which is recommended for the management of acute diarrhea in children to reduce the duration and severity of the episode. The resident is aware that the dose of zinc supplementation varies based on the age of the child and is determining the appropriate dose for this 7-month-old patient. What is the recommended dose of zinc supplementation for a 7-month-old child with acute diarrhea, to be given for a duration of 14 days?</span></p>",
      "unique_key": "Q7161318",
      "question_audio": null,
      "question_video": null,
      "map_id": 34192,
      "difficulty_level": "difficult",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. 20 mg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">When a <strong>zinc supplement</strong> is given during an episode of <strong>acute diarrhoea</strong>, it <strong>reduces</strong> the <strong>episode's duration and severity</strong>. In addition, <strong>zinc supplements</strong> given for <strong>10 to 14 days</strong> to <strong>lower</strong> the <strong>incidence of diarrhoea</strong> in the following <strong>2 to 3 months.</strong></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>WHO and UNICEF</strong> therefore recommend daily - <strong>10 mg of zinc</strong> for <strong>infants</strong> under <strong>6 months of age</strong>, and <strong>20 mg</strong> for <strong>children older</strong> than <strong>6 months for 10-14 days.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Some important Pointers -&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Micronutrient Zinc deficiency</strong> associated with <strong>rash and diarrhea</strong></span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Acrodermatitis enteropathica</strong> is due to <strong>Zinc deficiency</strong> (Clinical triad of <strong>acral dermatitis, alopecia and diarrhea</strong>)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Zinc deficiency</strong>: <strong>Growth failure, Sexual infantilism</strong>, <strong>Loss of taste</strong>, Delayed <strong>wound healing</strong>, Loss of integrity of <strong>immune system</strong>, Spontaneous abortions, Congenital malformations, <strong>Low birth weight</strong>, IUGR, Preterm delivery, <strong>Skin lesions</strong>, <strong>Depressed appetite</strong>, Skeletal abnormalities</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Banana</strong> is <strong>not</strong> a <strong>good source</strong> of: Calcium, Iron (Due to <strong>presence</strong> of <strong>phytates</strong>) and&nbsp;Zinc.</span></p></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Zinc supplementation</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Infants &lt; 6 months</strong> age: <strong>10 mg/day × 10–14 days.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Children &gt; 6 months</strong> age: <strong>20 mg/day × 10–14 days.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref</u>: Park 26<sup>th</sup> edition (page 264)</strong></span></p>",
      "correct_choice_id": 8104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3592,
      "choices": [
        {
          "id": 14347,
          "text": "<p><span style=\"font-size:12pt;\">Bacillus cereus</span></p>"
        },
        {
          "id": 14348,
          "text": "<p><span style=\"font-size:12pt;\">Botulism</span></p>"
        },
        {
          "id": 14349,
          "text": "<p><span style=\"font-size:12pt;\">Clostridium Perfringens&nbsp;</span></p>"
        },
        {
          "id": 14350,
          "text": "<p><span style=\"font-size:12pt;\">Staphylococcus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A medical resident is consulting on a case in the emergency department involving a group of individuals who presented with symptoms of food poisoning after attending a buffet. The resident is considering the various pathogens that could be responsible based on the type of onset and nature of the toxins involved. While some foodborne illnesses are caused by preformed toxins, others result from toxins produced in the body after consuming contaminated food. The resident needs to determine which pathogen in this scenario is least likely to be associated with preformed toxins in the context of food poisoning. In the case of the group presenting with food poisoning after a buffet, which pathogen is least likely to be associated with illness caused by preformed toxins?</span></p>",
      "unique_key": "Q5822898",
      "question_audio": null,
      "question_video": null,
      "map_id": 34193,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Clostridium perfringens</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Clostridium perfringens</strong> food poisoning: Is&nbsp;<strong>acute gastroenteritis</strong> caused by <strong>ingestion of contaminated food</strong> (symptoms are due to <strong>protein enterotoxin</strong> produced during <strong>sporulation </strong>of the organism in the <strong>intestine</strong>). <strong>IP 6–24</strong> <strong>hours</strong>;&nbsp;Symptoms are <strong>watery diarrhoea</strong> and <strong>abdominal cramps</strong>. Diagnosis is by identifying <strong>C. perfringens</strong> in <strong>contaminated food</strong> or in <strong>stool</strong>. Treatment is supportive.&nbsp;Rapid recovery with <strong>no deaths</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Bacillus cereus: Emetic type</strong> causes illness through the ingestion of <strong>preformed toxins</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Botulism:</strong> &nbsp;Is caused by the ingestion of a <strong>preformed toxin</strong> in <strong>contaminated food</strong>. The toxin is produced when the <strong>bacteria grow in food</strong> that has been <strong>improperly preserved</strong>, or <strong>stored under anaerobic conditions</strong>.<strong>&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Staphylococcus </strong>-&nbsp;<strong>Mechanism </strong>of<strong> </strong>food poisoning: <strong>Intra-dietetic toxins</strong> (ingestion of toxins pre-formed in food, in which <strong>bacteria</strong> have <strong>grown</strong>).&nbsp;Incubation period (<strong>1–6 hours</strong>) is <strong>short</strong> because of <strong>‘preformed</strong> <strong>toxin</strong>’.&nbsp;Toxins are <strong>relatively heat stable</strong> and <strong>resist </strong>boiling for <strong>30 min</strong> or more.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Clostridium botulinum, Staphylococcus aureus, and Bacillus cereus</strong> (<strong>emetic type</strong>) cause<strong> illness</strong> through the <strong>ingestion</strong> of <strong>preformed toxins</strong> present in the <strong>food</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Ref:</u> Park 26<sup>th</sup> edition (page 276)</strong></span></p>",
      "correct_choice_id": 14349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3596,
      "choices": [
        {
          "id": 14363,
          "text": "<p><span style=\"font-size:12pt;\">Chronic carrier</span></p>"
        },
        {
          "id": 14364,
          "text": "<p><span style=\"font-size:12pt;\">Contact carrier</span></p>"
        },
        {
          "id": 14365,
          "text": "<p><span style=\"font-size:12pt;\">Convalescent carrier</span></p>"
        },
        {
          "id": 14366,
          "text": "<p><span style=\"font-size:12pt;\">Incubatory carrier</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A public health physician is managing a recent outbreak of cholera in a coastal community. One of the patients, a 40-year-old man, has recently recovered from a severe case of cholera. Despite clinical recovery, follow-up testing reveals that he is still excreting Vibrio cholerae in his stool. This information is critical for the public health team in understanding the dynamics of disease transmission post-recovery. The physician needs to categorize this patient correctly in terms of carrier status to inform further public health actions. In the context of a cholera outbreak, how should the public health physician categorize a patient who continues to excrete Vibrio cholerae in his stool 2 to 3 weeks after clinical recovery?</span></p>",
      "unique_key": "Q9544783",
      "question_audio": null,
      "question_video": null,
      "map_id": 34198,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. &nbsp;C. Convalescent carrier</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>CONVALESCENT CARRIER</strong>: The patient who has <strong>recovered </strong>from an <strong>attack of</strong> <strong>cholera </strong>may continue to <strong>excrete vibrios</strong>, during his <strong>convalescence for 2-3 weeks.</strong> A convalescent state has been <strong>found to occur</strong> in patients who have <strong>not</strong> received effective <strong>antibiotic treatment</strong>. The convalescent carriers <strong>can</strong> often become <strong>chronic or long-term carriers</strong>. Example - <strong>Typhoid, Bacillary Dysentery,</strong> <strong>Amoebic Dysentery, Cholera, Diphtheria &amp; Pertussis</strong> (Clinical recovery does not coincide with bacteriological recovery)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Explanation:</u>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Chronic carrier:&nbsp; Excretes infectious agents</strong> for <strong>indefinite periods</strong> (&gt; 6 months).&nbsp;Example - Typhoid, Hepatitis-B, Dysentery, Meningococcal Meningitis, Malaria, Gonorrhoea, etc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Contact&nbsp;carrier: </strong>Carrier who gets <strong>infected from a case.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Incubatory&nbsp;carrier: Shed infectious agent</strong> during <strong>incubation period</strong> of disease.&nbsp;Example - <strong>Measles, Mumps, Polio, Pertussis, Influenza, Diphtheria, Hepatitis-B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Convalescent Carriers</strong>: Shed the <strong>disease agent</strong> during the <strong>period</strong> of <strong>Convalescence</strong>, e.g. <strong>Typhoid, Bacillary Dysentery, Amoebic Dysentery, Cholera, Diphtheria &amp; Pertussis</strong> (Clinical recovery does not coincide with bacteriological recovery)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Different types of carriers of a disease</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/08/screenshot-2024-08-08-122809.png\" alt=\"\" width=\"1000\" height=\"583\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Reference: Park 26<sup>th</sup> edition (page 267)</strong></span></p>",
      "correct_choice_id": 14365,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}